関連する実験動画
Updated: Sep 9, 2025

06:19
A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
Published on: January 7, 2018
10.5K
早期発症の胎児成長制限による妊娠における疾患進行に対する高血圧疾患の影響
Basia Chmielewska1, Claire Pegorie1, Michelle Jie1
1Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, UK.
Acta obstetricia et gynecologica Scandinavica
|September 2, 2025
まとめ
胎児成長制限 (FGR) の妊娠における高血圧は,早産につながり,出生体重に影響します. 妊婦と胎児の統合的なモニタリングは 高リスクの妊娠における結果を最適化するために不可欠です
科学分野:
- 産前医学
- 妊婦と胎児の医療
- 産婦人科
背景:
- 胎児の成長制限 (FGR) は,しばしば胎盤不全に関連した,胎児間疾患の主な原因です.
- 高血圧障害はしばしばFGR妊娠を複雑化し,臨床の経過と結果に影響を与えます.
研究 の 目的:
- FGRの妊娠における高血圧疾患の発症,進行,出産のタイミングへの影響を調査する.
- 高血圧と正常血圧のFGR妊娠における出産および新生児のアウトカムを比較する.
主な方法:
- 妊娠36週前に診断されたFGRを持つ196人の単体妊娠を遡及的なコホート研究.
- 妊婦の血圧による妊娠の階層化:正常血圧,高血圧妊娠障害,または慢性高血圧.
- 臨床的特徴,出産前の監視,出産の徴候,新生児のアウトカムをグループごとに比較する.
主要な成果:
- FGR妊娠の68%は高血圧 (慢性または新発症) であった.
- 妊娠中高血圧の場合,出産までの間隔 (9~12日 vs. 23日) と出産前の妊娠年齢 (29~30週 vs. 32週) が著しく短かった.
- 妊娠中高血圧は母親の指示によりより頻繁に出産され,妊娠中高血圧は動脈ドップラー異常によりより頻繁に出産され,新生児のアウトカムも同様であった.
結論:
- 高血圧は,FGR妊娠における出産のタイミングと出生体重センチルに大きな影響を及ぼします.
- 妊婦と胎児のモニタリングを統合したアプローチは,これらの症例での出産結果を最適化するために不可欠です.
関連する概念動画
Teratogenicity
2.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Hypertension V: Nursing Management
42
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
42
Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K

